June 14 Mei Pharma Inc
* Helsinn group and Mei Pharma announce first patient dosed in phase 2 dose-optimization study of pracinostat and azacitidine in myelodysplastic syndrome
* Mei Pharma says data from first stage is expected in Q1 of 2018 Source text for Eikon: Further company coverage:
GLOBAL MARKETS-Italy bank deal lifts Europe shares, dollar on back foot
* Italy bank deal lifts Europe shares; Asian stocks also rise
UPDATE 1-Britain's Co-op Bank says nears rescue deal with investor group
LONDON, June 26 Britain's Co-operative Bank said on Monday it was close to agreeing a financial rescue package with leading investors that would shore up its capital base and end months of uncertainty about its future.